- Open Access
miR-124 attenuates Japanese encephalitis virus replication by targeting DNM2
© The Author(s). 2016
- Received: 30 March 2016
- Accepted: 13 June 2016
- Published: 21 June 2016
Japanese encephalitis virus (JEV) is a mosquito-borne flavivirus that causes acute viral encephalitis in humans. Pigs are important amplifier hosts of JEV. Emerging evidence indicates that host microRNAs (miRNAs) play key roles in modulating viral infection and pathogenesis. However, mechanistic studies delineating the roles of miRNAs in regulating host-JEV interactions remain scarce.
In this study, we demonstrated that miR-124 inhibited JEV replication in porcine kidney epithelial PK15 cells. Furthermore, using bioinformatics tools, we identified dynamin2 (DNM2), a GTPase responsible for vesicle scission, as a target of miR-124. Small interfering RNA (siRNA) depletion studies inicated that dynamin2 was required for efficient JEV replication. We also demonstrated that upregulation of miR-124 expression corresponded to decreased expression of its target, DNM2, in the JEV-infected PK15 cells.
Overall, these results suggest the importance of miR-124 in modulating JEV replication and provide a scientific basis for using cellular miRNAs in anti-JEV therapies.
Japanese encephalitis virus (JEV) is a mosquito-borne neurotropic virus that belongs to the family flaviviridae. JEV is mostly prevalent in eastern, southeastern and southern Asian countries where three billion people are at risk of contracting the disease . A 2011 review estimated that the annual incidence was 1.8/100,000 and 5.4/100,000 for children 0-14 years old in 24 JEV endemic countries . JEV is transmitted in an enzootic cycle between mosquito vectors and vertebrate hosts; humans contract JEV when bitten by an infected mosquito. Pigs act as amplifying hosts of JEV; therefore, the domestic pig was considered to be a risk factor in the transmission of the disease to humans [3, 4]. JEV is also one of the main causes of infectious reproductive failure in swine, and this has resulted in significant economic losses for the swine industry. The primary symptoms of pigs infected with JEV are fetal abortion and stillbirth in infected sows and aspermia in boars [5, 6]. In order to elucidate the pathogenesis of JEV in pigs, numerous studies on JEV have been conducted in PK-15 cells, a porcine kidney epithelial cell line, which have a similar susceptibility as skin epithelial cells to JEV [7–9]. Therefore, PK-15 cells are a good model in which to evaluate the host response to JEV infection.
MicroRNAs (miRNAs) are small non-coding RNAs of approximately 22 nucleotides in length, which play a crucial role in the post-transcriptional regulation of genes involved in fundamental biological processes, including cell differentiation, proliferation, apoptosis and cell signaling [10, 11]. miRNAs regulate gene expression by guiding the RNA-induced silencing complex (RISC) to partially complementary sites within the 3’ UTR of target mRNAs via their seed region . miRNAs have been shown to regulate the host antiviral response by altering the expression of host genes required for virus replication and antiviral response [13–16] or by directly targeting viral genomes and/or transcripts. [17–20]
Recent studies suggest that miRNAs play a notable role in cellular immune response during Japanese encephalitis virus infection [21–24]. For example, miR-15b and miR-155 were shown to induce an inflammatory response in JEV-infected microglial cells via suppression of RNF125  and SHIP1 , respectively, whereas miR-146a was shown to inhibit the immune response against JEV by suppressing the JAK/STAT pathway in mouse monocytes . In addition, miR-29b regulated JEV-induced microglia activation, and miR-155 suppressed JEV replication and negatively modulated innate immune responses in microglial cells [24, 25].
In this study, we investigated the role of host miRNAs in JEV infection of porcine cells. We show that expression of miR-124 is upregulated in response to JEV infection and that this results in the suppression of the target gene, DNM2, which is required for virus replication. Thus, we conclude that upregulation of miR-124 and the subsequent suppression of DNM2 represents a host response aimed at limiting JEV infection. Our study reveals an example of a miRNA that modulates JEV replication and also highlights a host factor that could be used for RNAi-mediated antiviral therapeutic strategies.
miR-124 inhibits JEV replication
JEV enters the central nervous system and propagates in the neurons, causing a disruption to the blood–brain barrier that results in acute viral encephalitis in humans [26, 27]. miR-124 is highly expressed in neurons (representing 25 % to 48 % of all brain miRNAs), and it was first cloned from the mouse brain where it was later found to mediate neuronal differentiation [28, 29]. In addition, recent studies showed that miR-124 was differentially expressed in JEV-infected porcine cells . Therefore, miR-124 may play a notable role in JEV infection.
JEV genomic RNA is not a target of miR-124
Host miRNAs were shown to influence the life cycle of RNA viruses by altering host cell gene expression [31, 32]. In addition, many miRNAs have been shown to interact directly with the viral genome RNA to inhibit virus replication [33–35]. In order to determine whether miR-124 inhibits JEV replication via a direct interaction with viral RNA, computational screening of viral RNA for potential miR-124 binding sites was performed.
These predictions were then validated by a luciferase reporter assay. Nucleotide sequences from JEV RNA predicted to interact with miR-124 were inserted into the 3’UTR of h-luc in the psiCHECK-2 vector. BHK-21 cells were co-transfected with the reporter construct and miR-124 mimic, and then assayed for luciferase activity at 24 h post-transfection (hpt). However, transfection of the miR-124 mimic did not significantly alter the expression of luciferase from the reporter constructs bearing either of the predicted miR-124 target sites from the JEV RNA (Fig. 2B). Therefore, the mechanism by which miR-124 inhibits virus replication is likely to involve miR-124-mediated regulation of host genes.
DNM2 is a target of miR-124
To confirm that miR-124 directly targets the 3’UTR of DNM2, dual-luciferase reporter plasmids (psiCHECK2 Vector) carrying the DNM2 3’UTR with the wild-type or base-pair mutant miR-124 binding regions was constructed (Fig. 3A). After co-transfection of BHK-21 cells with psiCHECK2-DNM2 3’UTR and miR-124 mimic, the luciferase activity was measured at 24 hpt. Luciferase activity markedly decreased when cells were co-transfected with the miR-124 mimic and wild-type or mutant target site1(Mut1) DNM2 3’UTR plasmids in comparison with NC mimic (Fig. 3B). However, the DNM2 3’UTR Mut2 reversed the inhibition of luciferase activity compared to DNM2 3’UTR wild-type (Fig. 3B). Therefore,
DNM2 is required for JEV replication
miR-124 and DNM2 are inversely affected by JEV infection
MicroRNAs serve as multifunctional regulators, and the significance of miRNAs in virus-host interactions is becoming evident. A growing number of studies show that host miRNAs can drastically influence virus replication, either by facilitating enhanced replication  or by mediating the host antiviral response . Therefore, many viruses, including JEV, modulate the expression of specific cellular miRNAs [22–25]. JEV is a significant pathogen of acute CNS inflammatory disease in humans. In addition, pigs act as amplifying hosts of JEV. However, the role of host miRNAs in JEV-host interactions and pathogenesis has not been extensively studied.
miR-124 is highly expressed in neurons, and it plays a notable role in neuronal differentiation . In addition, miR-124 was attenuated in several tumors, and the overexpression of miR-124 inhibited the metastasis of breast cancer and hepatocellular carcinoma [41, 42]. Interestingly, previous studies showed that miR-124 could play an important role in virus entry by disturbing receptor-mediated endocytosis, and miR-124 was upregulated in JEV-infected porcine cells [30, 43]. These results suggest that miR-124 may be involved in the regulation of JEV infection. In order to determine the biological role of miR-124 in the host response to JEV infection, miR-124 was overexpressed through miRNA mimic transfection in order to assess its effect on JEV replication. The flow cytometry and Western blot experiments revealed that miR-124 exhibited a significant antiviral effect (Fig. 1). Thus, the key new finding of this study is that miR-124 is an anti-JEV miRNA.
miRNAs regulate many biological processes by interacting with their target genes. Host miRNAs were previously shown to directly target viral genomic RNAs; for example, miR-122 facilitates hepatitis C virus replication , while miR-130b and miR-181 suppress the porcine reproductive and respiratory syndrome virus (PRRSV) [19, 45]. According to the online software analysis, there were two potential miR-124 binding sites in the JEV genomic RNA. However, the luciferase reporter assay showed that miR-124 does not directly interact with the 2 predicted sites in the JEV RNA (Fig. 2). These data indicate that the antiviral effect of miR-124 is mediated by its interaction with the host genes. In order to test this hypothesis, we screened for miR-124 targets using TargetScan and ultimately focused on the DNM2 gene. The luciferase reporter assay showed that miR-124 directly interacts with the 3’ UTR of DNM2 and that DNM2 mRNA and protein levels were reduced in cells overexpressing miR-124 (Figs. 3 and 4).
Dynamin-2, a GTPase responsible for vesicle scission, forms helical polymers around the membrane neck of nascent endocytic buds and, upon GTP hydrolysis, mediates the fission of vesicles from the plasma membrane . Thus, the research showed that other factors may assist with the action of dynamin-2 in vivo because dynamin-2 is sufficient to mediate membrane fission . In addition, dynamin-2 was required for the caveolae and clathrin-mediated endocytosis pathways [47, 48]. We previously found that JEV infected PK15 cells via clathrin-dependent endocytosis , and miR-124 reduced caveolar density in porcine PK15 cells . Therefore, dynamin-2 may play an important role in JEV infection. Indeed, siRNA knockdown was performed in order to assess its effect on JEV replication in DNM2 depleted cells. The knockdown experiment demonstrated that dynamin-2 was required for JEV replication (Fig. 5). However, the step at which the inhibition of JEV infection by dynamin-2 occurs, perhaps at entry, still needs to be demonstrated.
Previous studies using high-throughput sequencing technology found that miR-124 was downregulated by JEV in swine testis cells . In this study, quantitative methods were used to determine expression levels of miR-124 in PK15 cells before and after JEV infection. The results confirmed the previous reports and further showed that miR-124 was upregulated immediately upon infection (4 hpi) and remained upregulated throughout the infection. In contrast, DNM2 expression levels increased during early JEV infection (first 12 hpi) and then sharply declined (24 hpi) in mRNA level, however, DNM2 protein level always remained downregulated throughout the infection (Fig. 6). Considering the important role of DNM2 in the regulation of virus entry, it is possible that miR-124-mediated suppression of DNM2 expression may block JEV-induced vesicle scission, thereby contributing to the antiviral effect of miR-124. However, miR-124 may also target other host regulators, and their roles in JEV replication may have yet to be evaluated.
Taken together, this study demonstrates that overexpression of miR-124 inhibits JEV replication in PK15 cells. Subsequently, miR-124 suppresses expression of the DNM2 gene via targeting its 3’ UTR sequence. DNM2 is required for efficient JEV replication. In addition, the expression of miR-124 and DNM2 is inversely affected by JEV infection. This finding implies that the miR-124-DNM2-pathway plays an important role in the suppression of virus replication. These findings further highlight that mammalian miRNAs may have important implications for controlling virus infections.
Cell culture, transfection and viral infection
PK15 and baby hamster kidney (BHK-21) cell lines (obtained from the American Type Culture Collection, Manassas, VA) were grown in Dulbecco’s Modified Eagle Medium (DMEM, High glucose, Thermo Scientific Hyclone, Beijing, China) supplemented with 10 % fetal bovine serum (Gibco, Life Technologies, Austin, TX) and maintained in a humidified incubator at 37 °C and 5 % CO2.
The miRNA mimics and siRNA (siDNM2) were synthesized by GenePharma (Shanghai, China). The sequences of siDNM2 and mimics were as follows: siDNM2 5’-GGACAUGAUCCUGCAGUUTT-3’ , miR-124 mimics: 5’- UAAGGCACGCGGUGAAUGCCA-3’, NC (Negative control): 5’-UUCUCCGAACGUGUCACGUTT-3’. PK15 cells were seeded in 24- or 6-well plates and grown to approximately 50 % confluence for transfection. The cells were transfected with 50 pmol miRNA mimics or siDNM2 using Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA) according to the manufacturer’s protocol. The cells were cultured at the indicated times before harvesting.
The JEV attenuated strain SA14-14-2 (GenBank accession: AF315119.1) was propagated in BHK-21 cells as described previously . All infections were carried out by incubating the cells with a small volume of medium (300 μL in per well of 6-well cell culture plate) containing virus at the MOI = 1, then the inoculum was removed, the cells were washed three times with Phosphate Buffered Saline (PBS, Thermo Scientific Hyclone, Beijing, China) and fresh media was added. Infections were performed and the infected cells were maintained in DMEM supplemented with 2 % FBS.
RNA extraction, reverse transcription, and quantitative real-time PCR (qPCR)
Primers used for reverse transcription, real-time quantification PCR
Protein extraction and western blot
Cells were harvested 48 h after transfection, and lysates were prepared using RIPA buffer (50 mM Tris (pH 7.4), 150 mM NaCl, 1 % Triton X-100, 1 % sodium deoxycholate, 0.1 % SDS, 1 mM phenylmethylsulfonyl fluoride [PMSF], Beyotime, China). The protein concentration was determined with the BCA Protein Assay kit (Solarbio, China). Equal amounts of protein lysate were separated on 12 % SDS-polyacrylamide gels and transferred to PVDF membranes (Millipore). The membranes were blocked with 5 % nonfat milk in Tris-buffered saline containing 0.1 % Tween-20 (TBST) and then incubated with primary antibodies specific for mouse anti-JEV E, goat anti-Dynamin-2 (sc-6400, Santa Cruz), or rabbit anti-ß-Actin (#4967,1:1000, Cell Signaling) overnight at 4 °C. Membranes were then washed three times and incubated with a horseradish peroxidase-conjugated secondary antibody (Proteintech Group, Wuhan, China) for 1 h at ambient temperature. Finally, protein bands were visualized by addition of the SuperSignal West Pico chemiluminescent substrate (Thermo, Rockford, IL), with β-actin as a control. The mean densities of the protein bands were measured by ImageJ software (National Institutes of Health, Bethesda, Maryland).
Plasmid construction and luciferase reporter assay
Primers used for luciferase reporter gene vector construct
PK15 cells infected with JEV were washed one time with PBS, detached and transferred to 1.5 ml centrifuge tubes. The cells were centrifuged at 1000 rpm/min for 10 min and fixed with 4 % paraformaldehyde (Solarbio, Beijing, China) for 15 min at room temperature. After being permeabilized with Triton X-100(amresco, Solon, OH), the cells were incubated with mouse anti-JEV E antibody overnight at 4 °C. The cells were washed 3 times with PBS then incubated with Alexa Fluor 488 goat anti-mouse IgG (Invitrogen) at 1:200 for 1 h at room temperature and protected from light. The cells were washed with PBS, resuspended in 500 μl PBS and analyzed using a FACScan flow cytometer with CellQuest pro software (BD Biosciences, San Jose, CA). The cells were counted as infected if their fluorescence density was greater than the intensity of the uninfected cells. The amount of infected cells relative to the untreated or siCtrl-transfected controls was given as percent infection. At least 10,000 cells were analyzed per sample. Three independent experiments were performed in triplicate.
The results were presented as the mean ± standard deviation (SD). Statistical significance was assessed by Student’s t-test, and statistical significance was ascribed when *p < 0.05, **p < 0.01.
This work was supported by the National Natural Science Foundation of China (31501921, 31372302), the Zhejiang Provincial Natural Science Foundation of China (LQ15C170001) and the Research Development Foundation of Zhejiang A&F University (2014FR068). We acknowledge Professor Shengbo Cao (Huazhong Agriculture University, Wuhan, China) for generously providing the JEV E protein antibody and JEV attenuated strain.
S.Y. carried out most of the experiments and drafted the manuscript. Y.P. and Y.L. participated in the experiments. S.Z., M.Z. and A.Z. designed the study, supervised the work and edited the final version of this manuscript. All authors have read and approved the final version of the manuscript.
The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Solomon T. Control of Japanese encephalitis--within our grasp? N Engl J Med. 2006;355:869–71.View ArticlePubMedGoogle Scholar
- Campbell GL, Hills SL, Fischer M, Jacobson JA, Hoke CH, Hombach JM, Marfin AA, Solomon T, Tsai TF, Tsu VD, Ginsburg AS. Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ. 2011;89:766–74. 774A-774E.View ArticlePubMedPubMed CentralGoogle Scholar
- van den Hurk AF, Ritchie SA, Mackenzie JS. Ecology and geographical expansion of Japanese encephalitis virus. Annu Rev Entomol. 2009;54:17–35.View ArticlePubMedGoogle Scholar
- Erlanger TE, Weiss S, Keiser J, Utzinger J, Wiedenmayer K. Past, present, and future of Japanese encephalitis. Emerg Infect Dis. 2009;15:1–7.View ArticlePubMedPubMed CentralGoogle Scholar
- Takashima I, Watanabe T, Ouchi N, Hashimoto N. Ecological studies of Japanese encephalitis virus in Hokkaido: interepidemic outbreaks of swine abortion and evidence for the virus to overwinter locally. Am J Trop Med Hyg. 1988;38:420–7.PubMedGoogle Scholar
- Burns KF. Congenital Japanese B encephalitis infection of swine. Proc Soc Exp Biol Med. 1950;75:621–5.View ArticlePubMedGoogle Scholar
- Liu K, Liao X, Zhou B, Yao H, Fan S, Chen P, Miao D. Porcine alpha interferon inhibit Japanese encephalitis virus replication by different ISGs in vitro. Res Vet Sci. 2013;95:950–6.View ArticlePubMedGoogle Scholar
- Yang S, He M, Liu X, Li X, Fan B, Zhao S. Japanese encephalitis virus infects porcine kidney epithelial PK15 cells via clathrin- and cholesterol-dependent endocytosis. Virol J. 2013;10:258.View ArticlePubMedPubMed CentralGoogle Scholar
- Cai Y, Zhu L, Zhou Y, Liu X, Li X, Lang Q, Qiao X, Xu Z. Identification and analysis of differentially-expressed microRNAs in Japanese encephalitis virus-infected PK-15 cells with deep sequencing. Int J Mol Sci. 2015;16:2204–19.View ArticlePubMedPubMed CentralGoogle Scholar
- Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–97.View ArticlePubMedGoogle Scholar
- Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857–66.View ArticlePubMedGoogle Scholar
- Carthew RW, Sontheimer EJ. Origins and Mechanisms of miRNAs and siRNAs. Cell. 2009;136:642–55.View ArticlePubMedPubMed CentralGoogle Scholar
- Fu YR, Liu XJ, Li XJ, Shen ZZ, Yang B, Wu CC, Li JF, Miao LF, Ye HQ, Qiao GH, Rayner S, Chavanas S, Davrinche C, Britt WJ, Tang Q, McVoy M, Mocarski E, Luo MH. MicroRNA miR-21 attenuates human cytomegalovirus replication in neural cells by targeting Cdc25a. J Virol. 2015;89:1070–82.View ArticlePubMedGoogle Scholar
- Tang WF, Huang RT, Chien KY, Huang JY, Lau KS, Jheng JR, Chiu CH, Wu TY, Chen CY, Horng JT. Host miR-197 plays a negative regulatory role in the enterovirus 71 infectious cycle by targeting the RAN protein. J Virol. 2015;18:1424–38.Google Scholar
- Huang JY, Chou SF, Lee JW, Chen HL, Chen CM, Tao MH, Shih C. MicroRNA-130a can inhibit hepatitis B virus replication via targeting PGC1alpha and PPARgamma. RNA. 2015;21:385–400.View ArticlePubMedPubMed CentralGoogle Scholar
- Zhao L, Zhu J, Zhou H, Zhao Z, Zou Z, Liu X, Lin X, Zhang X, Deng X, Wang R, Chen H, Jin M. Identification of cellular microRNA-136 as a dual regulator of RIG-I-mediated innate immunity that antagonizes H5N1 IAV replication in A549 cells. Sci Rep. 2015;5:14991.View ArticlePubMedPubMed CentralGoogle Scholar
- Bai XT, Nicot C. miR-28-3p is a cellular restriction factor that inhibits HTLV-1 replication and virus infection. J Biol Chem. 2015;27:5381–90.View ArticleGoogle Scholar
- Skalsky RL, Cullen BR. Viruses, microRNAs, and host interactions. Annu Rev Microbiol. 2010;64:123–41.View ArticlePubMedPubMed CentralGoogle Scholar
- Li L, Gao F, Jiang Y, Yu L, Zhou Y, Zheng H, Tong W, Yang S, Xia T, Qu Z, Tong G. Cellular miR-130b inhibits replication of porcine reproductive and respiratory syndrome virus in vitro and in vivo. Sci Rep. 2015;5:17010.View ArticlePubMedPubMed CentralGoogle Scholar
- Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science. 2005;309:1577–81.View ArticlePubMedGoogle Scholar
- Zhu B, Ye J, Nie Y, Ashraf U, Zohaib A, Duan X, Fu ZF, Song Y, Chen H, Cao S. MicroRNA-15b Modulates Japanese Encephalitis Virus-Mediated Inflammation via Targeting RNF125. J Immunol. 2015;195:2251–62.View ArticlePubMedGoogle Scholar
- Sharma N, Verma R, Kumawat KL, Basu A, Singh SK. miR-146a suppresses cellular immune response during Japanese encephalitis virus JaOArS982 strain infection in human microglial cells. J Neuroinflammation. 2015;12:30.View ArticlePubMedPubMed CentralGoogle Scholar
- Thounaojam MC, Kundu K, Kaushik DK, Swaroop S, Mahadevan A, Shankar SK, Basu A. MicroRNA 155 regulates Japanese encephalitis virus-induced inflammatory response by targeting Src homology 2-containing inositol phosphatase 1. J Virol. 2014;88:4798–810.View ArticlePubMedPubMed CentralGoogle Scholar
- Pareek S, Roy S, Kumari B, Jain P, Banerjee A, Vrati S. MiR-155 induction in microglial cells suppresses Japanese encephalitis virus replication and negatively modulates innate immune responses. J Neuroinflammation. 2014;11:97.View ArticlePubMedPubMed CentralGoogle Scholar
- Thounaojam MC, Kaushik DK, Kundu K, Basu A. MicroRNA-29b modulates Japanese encephalitis virus-induced microglia activation by targeting tumor necrosis factor alpha-induced protein 3. J Neurochem. 2014;129:143–54.View ArticlePubMedGoogle Scholar
- Li F, Wang Y, Yu L, Cao S, Wang K, Yuan J, Wang C, Cui M, Fu ZF. Viral Infection of the Central Nervous System and Neuroinflammation Precede Blood-Brain Barrier Disruption during Japanese Encephalitis Virus Infection. J Virol. 2015;89:5602–14.View ArticlePubMedPubMed CentralGoogle Scholar
- Chen CJ, Ou YC, Li JR, Chang CY, Pan HC, Lai CY, Liao SL, Raung SL, Chang CJ. Infection of pericytes in vitro by Japanese encephalitis virus disrupts the integrity of the endothelial barrier. J Virol. 2014;88:1150–61.View ArticlePubMedPubMed CentralGoogle Scholar
- Makeyev EV, Zhang J, Carrasco MA, Maniatis T. The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol Cell. 2007;27:435–48.View ArticlePubMedPubMed CentralGoogle Scholar
- Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. Identification of Tissue-Specific MicroRNAs from Mouse. Curr Biol. 2002;12:735–9.View ArticlePubMedGoogle Scholar
- Zhang Y, Jing J, Li X, Wang J, Feng X, Cao R, Chen P. Integration analysis of miRNA and mRNA expression profiles in swine testis cells infected with Japanese encephalitis virus. Infect Genet Evol. 2015;32:342–7.View ArticlePubMedGoogle Scholar
- Zhu X, He Z, Hu Y, Wen W, Lin C, Yu J, Pan J, Li R, Deng H, Liao S, Yuan J, Wu J, Li J, Li M. MicroRNA-30e* Suppresses Dengue Virus Replication by Promoting NF-kappaB-Dependent IFN Production. PLoS Negl Trop Dis. 2014;8:e3088.View ArticlePubMedPubMed CentralGoogle Scholar
- Zhao F, Xu G, Zhou Y, Wang L, Xie J, Ren S, Liu S, Zhu Y. MicroRNA-26b Inhibits Hepatitis B Virus Transcription and Replication by Targeting the Host Factor CHORDC1. J Biol Chem. 2014;289:35029–41.View ArticlePubMedPubMed CentralGoogle Scholar
- Zhou Z, Li X, Liu J, Dong L, Chen Q, Kong H, Zhang Q, Qi X, Hou D, Zhang L,Zhang G, Liu Y, Zhang Y, Li J, Wang J,Chen X,Wang H, Zhang J, Chen H, Zen K, Zhang CY. Honeysuckle-encoded atypical microRNA2911 directly targets influenza A viruses. Cell Res. 2014;25:39–49.View ArticlePubMedPubMed CentralGoogle Scholar
- Zhang Q, Guo XK, Gao L, Huang C, Li N, Jia X, Liu W, Feng WH, MicroRNA-23 inhibits PRRSV replication by directly targeting PRRSV RNA and possibly by upregulating type I interferons. Virology. 2014;450–451:182–95.View ArticlePubMedGoogle Scholar
- Zheng Z, Ke X, Wang M, He S, Li Q, Zheng C, Zhang Z, Liu Y, Wang H. Human microRNA hsa-miR-296-5p suppresses enterovirus 71 replication by targeting the viral genome. J Virol. 2013;87:5645–56.View ArticlePubMedPubMed CentralGoogle Scholar
- Hsu PW, Lin LZ, Hsu SD, Hsu JB, Huang HD. ViTa: prediction of host microRNAs targets on viruses. Nucleic Acids Res. 2007;35:D381–5.View ArticlePubMedGoogle Scholar
- Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120:15–20.View ArticlePubMedGoogle Scholar
- Kalia M, Khasa R, Sharma M, Nain M, Vrati S. Japanese Encephalitis Virus Infects Neuronal Cells through a Clathrin Independent Endocytic Mechanism. J Virol. 2012;87:148–62.View ArticlePubMedGoogle Scholar
- Zhu YZ, Xu QQ, Wu DG, Ren H, Zhao P, Lao WG, Wang Y, Tao QY, Qian XJ, Wei YH, Cao MM, Qi ZT. Japanese encephalitis virus enters rat neuroblastoma cells via a pH-dependent, dynamin and caveola-mediated endocytosis pathway. J Virol. 2012;86:13407–22.View ArticlePubMedPubMed CentralGoogle Scholar
- Ru J, Sun H, Fan H, Wang C, Li Y, Liu M, Tang H. MiR-23a facilitates the replication of HSV-1 through the suppression of interferon regulatory factor 1. PLoS One. 2014;9:e114021.View ArticlePubMedPubMed CentralGoogle Scholar
- Liang YJ, Wang QY, Zhou CX, Yin QQ, He M, Yu XT, Cao DX, Chen GQ, He JR, Zhao Q. MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer. Carcinogenesis. 2013;34:713–22.View ArticlePubMedGoogle Scholar
- Zheng F, Liao YJ, Cai MY, Liu YH, Liu TH, Chen SP, Bian XW, Guan XY, Lin MC, Zeng YX, Kung HF, Xie D. The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut. 2011;61:278–89.View ArticlePubMedGoogle Scholar
- Yang S, Liu X, Li X, Sun S, Sun F, Fan B, Zhao S. MicroRNA-124 reduces caveolar density by targeting caveolin-1 in porcine kidney epithelial PK15 cells. Mol Cell Biochem. 2013;384:213–9.View ArticlePubMedGoogle Scholar
- Bandiera S, Pfeffer S, Baumert TF, Zeisel MB. miR-122 - a key factor and therapeutic target in liver disease. J Hepatol. 2015;62:448–57.View ArticlePubMedGoogle Scholar
- Gao L, Guo XK, Wang L, Zhang Q, Li N, Chen XX, Wang Y, Feng WH. MicroRNA 181 suppresses porcine reproductive and respiratory syndrome virus (PRRSV) infection by targeting PRRSV receptor CD163. J Virol. 2013;87:8808–12.View ArticlePubMedPubMed CentralGoogle Scholar
- Doherty GJ, McMahon HT. Mechanisms of endocytosis. Annu Rev Biochem. 2009;78:857–902.View ArticlePubMedGoogle Scholar
- Ferguson SM, De Camilli P. Dynamin, a membrane-remodelling GTPase. Nat Rev Mol Cell Biol. 2012;13:75–88.PubMedPubMed CentralGoogle Scholar
- Sandvig K, Pust S, Skotland T, van Deurs B. Clathrin-independent endocytosis: mechanisms and function. Curr Opin Cell Biol. 2011;23:413–20.View ArticlePubMedGoogle Scholar
- Romer W, Berland L, Chambon V, Gaus K, Windschiegl B, Tenza D, Aly MR, Fraisier V, Florent JC, Perrais D, Lamaze C, Raposo G, Steinem C, Sens P, Bassereau P, Johannes L. Shiga toxin induces tubular membrane invaginations for its uptake into cells. Nature. 2007;450:670–5.View ArticlePubMedGoogle Scholar
- Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, Guegler KJ. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005;33:e179.View ArticlePubMedPubMed CentralGoogle Scholar
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–8.View ArticlePubMedGoogle Scholar